The IMID Forum

The global effort improving patient outcomes amid COVID-19. Past President of EULAR Prof Johannes Bijlsma discusses global rheumatology registries for COVID-19 with EULAR registry group member Prof K...

24 Huhti 202022min

COVID-19 guidance for rheumatologists. Prof Peter Nash discusses the challenges COVID-19 poses with infections specialist Prof Kevin Winthrop.

22 Huhti 202031min

First to identify destructive properties of IL-17 and received the prestigious Carol Nachman prize in 2010 for his contribution. In this podcast, Prof Pierre Miossec discusses the pathophysiology of R...

9 Huhti 20208min

Timo Gaber and Paula Hoff from Charité Berlin. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, the impact of tofacitinib on the bone healing pr...

2 Huhti 202019min

Prof Schett from University of Erlangen-Nuremberg. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Prof Schett discusses how JAK inhibitors can...

27 Maalis 202023min

Prof Iain McInnes discusses bone homeostasis. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed in this podcast is available in a more d...

23 Maalis 20207min

Muirhead Professor of Medicine, President of EULAR, and Sir James Black Prize Medal winner. In this podcast, Prof Iain McInnes discusses the inception of JAK inhibitors during his time at the National...

11 Maalis 202012min

Dr Giovanni Orsolini from the University of Verona. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Dr Giovanni Orsolini discusses the potential of JAK inhibito...

26 Helmi 202020min